drug

AI and multiomics identify cancer biomarker and drug target

AI and multiomics identify cancer biomarker and drug target

Source: MasterTux/Pixabay Artificial intelligence (AI) machine learning has the potential to completely revolutionize not only how diseases are detected, but also how to identify personalized treatment based on a patient’s genomics. A new study published in Cell death and diseasepeer review Nature journal, shows how an AI-based multiomics platform can identify novel biomarkers for new …

AI and multiomics identify cancer biomarker and drug target Read More »

Neuroscience News logo for mobile.

New drug, promising breakthrough for incurable neurodegenerative myelin diseases – Neuroscience News

Summary: Riluzole, an FDA-approved drug to treat ALS, may, in part, correct the molecular cause of some leukodystrophies. Source: Montreal university There is new hope for the future treatment of certain leukodystrophies, neurodegenerative diseases in young children that progressively affect their quality of life, often leading to death before adulthood. The development stems from the …

New drug, promising breakthrough for incurable neurodegenerative myelin diseases – Neuroscience News Read More »

Accelerating Drug Discovery with Hybrid Quantum Computing |  NVIDIA Blog

Accelerating Drug Discovery with Hybrid Quantum Computing | NVIDIA Blog

The promise of quantum computing is to solve unsolvable problems. And companies are already making progress with hybrid approaches — those that combine classical and quantum computing — to tackle challenges like drug discovery for incurable diseases. By accelerating the simulation and modeling of drug molecules using hybrid quantum computing, startup Qubit Pharmaceuticals is dramatically …

Accelerating Drug Discovery with Hybrid Quantum Computing | NVIDIA Blog Read More »